Treatment-emergent potential impaired glucose tolerance and potential diabetes with olanzapine compared to other antipsychotic agents and placebo

被引:0
|
作者
Beasley, CM [1 ]
Berg, PH [1 ]
Dananberg, J [1 ]
Kwong, KC [1 ]
Taylor, CCM [1 ]
Breier, A [1 ]
机构
[1] Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA
关键词
D O I
暂无
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
421
引用
收藏
页码:121S / 121S
页数:1
相关论文
共 17 条
  • [1] Treatment-emergent potential impaired glucose tolerance and potential diabetes with olanzapine compared to other antipsychotic agents and placebo
    Breier, A
    Beasley, CM
    Berg, PH
    [J]. SCHIZOPHRENIA RESEARCH, 2001, 49 (1-2) : 221 - 221
  • [2] Risk of treatment-emergent diabetes during clinical trials of olanzapine and other antipsychotic medications
    Toalson, P
    Sowell, M
    Mukhopdhyay, N
    Cavazzoni, P
    Breier, A
    Buse, J
    [J]. PSYCHOSOMATICS, 2003, 44 (02) : 148 - 148
  • [3] Orally disintegrating olanzapine and potential differences in treatment-emergent weight gain
    Karagianis, Jamie
    Hoffmann, Vicki Poole
    Arranz, Belen
    Treue, Tamas
    Maguire, Gerald A.
    de Haan, Lieuwe
    Chawla, Bharat
    [J]. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2008, 23 (04) : 275 - 281
  • [4] Potential atypical antipsychotic agents with with reduced liability for treatment emergent weight gain
    Thompson, L. K.
    Evans, D. C.
    Falcone, J. F.
    Bymaster, F. P.
    Schaus, J. M.
    Martin, F.
    Tupper, D.
    Owton, W.
    Rocco, V. P.
    Pineiro-Nunez, M.
    Chen, Z.
    Yang, Y.
    Rasmussen, K.
    Hemrick-Luecke, S. K.
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S138 - S138
  • [5] Diabetes mellitus and impaired glucose tolerance in patients with schizophrenia, before and after antipsychotic treatment
    Wani, Rayees Ahmad
    Dar, Mansoor Ahmad
    Margoob, Mushtaq Ahmad
    Haq, Yasir Hassan Rather Inaamul
    Haq, Inaamul
    Shah, Majid Shafi
    [J]. JOURNAL OF NEUROSCIENCES IN RURAL PRACTICE, 2015, 6 (01) : 17 - 22
  • [7] Potential of α-glucosidase inhibitors in elderly patients with diabetes mellitus and impaired glucose tolerance
    Rabasa-Lhoret, R
    Chiasson, JL
    [J]. DRUGS & AGING, 1998, 13 (02) : 131 - 143
  • [8] Potential of α-Glucosidase Inhibitors in Elderly Patients with Diabetes Mellitus and Impaired Glucose Tolerance
    Rémi Rabasa-Lhoret
    Jean-Louis Chiasson
    [J]. Drugs & Aging, 1998, 13 : 131 - 143
  • [9] Potential predictive factors for development of treatment-emergent suicidal ideation in the fluoxetine placebo-controlled major depressive disorder database
    Beasley, Charles
    Disch, Damon
    Prabhakar, Venkat
    Desaiah, Durisala
    Tamura, Roy
    Perlis, Roy
    [J]. NEUROPSYCHOPHARMACOLOGY, 2006, 31 : S100 - S101
  • [10] The potential for lifestyle change to influence the progression of impaired glucose tolerance to non-insulin-dependent diabetes mellitus
    Bourn, DM
    [J]. DIABETIC MEDICINE, 1996, 13 (11) : 938 - 945